Regencell Bioscience Holdings Ltd
RGC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001829667
No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Regencell Bioscience Holdings Ltd as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 5
- 0 vs. Q1 2022
- Shares held
- 8.50K
- −11.7K (−58.0%) vs. Q1 2022
- Total value
- $296.0K
- −$138.0K (−31.8%) vs. Q1 2022
- New holders
- 2
- 3 more added
- Sold out
- 2
- 0 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $8.56M |
| Q1 2026 | 31 | $16.5M |
| Q4 2025 | 17 | $11.5M |
| Q3 2025 | 16 | $9.79M |
| Q2 2025 | 14 | $11.8M |
| Q1 2025 | 5 | $281.3K |
| Q4 2024 | 3 | $155.9K |
| Q3 2024 | 2 | $100.4K |
| Q2 2024 | 3 | $1.89K |
| Q1 2024 | 3 | $7.43K |
| Q4 2023 | 3 | $171.2K |
| Q3 2023 | 4 | $9.27K |
| Q2 2023 | 2 | $11.7K |
| Q1 2023 | 4 | $18.9K |
| Q4 2022 | 3 | $32.3K |
| Q3 2022 | 5 | $260.0K |
| Q2 2022 | 5 | $296.0K |
| Q1 2022 | 5 | $434.0K |
| Q4 2021 | 2 | $230.0K |
| Q3 2021 | 3 | $316.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Regencell Bioscience Holdings Ltd; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 6,816 | $238.0K | 0.00% | +6,816 | New |
| UBS Group AG | 723 | $25.0K | 0.00% | +479+196.3% | Added |
| Tower Research Capital LLC (TRC) | 578 | $20.0K | 0.00% | +146+33.8% | Added |
| BlackRock Inc. | 238 | $8.00K | 0.00% | +238 | New |
| Morgan Stanley | 149 | $5.00K | 0.00% | +143+2,383.3% | Added |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −17,329−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2,240−100.0% | Sold out |